| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 06/24/1997 | US5641861 μopioid receptor ligands: agonists and antagonists |
| 06/24/1997 | US5641837 Method of detecting collagen degradation in vivo |
| 06/24/1997 | US5641752 Methods of using endothelin antagonists |
| 06/24/1997 | US5641687 Contacting body fluid with immunological binding partner which binds to specified crosslinked collagen telopeptide, detecting binding, correlating with collagen degradation |
| 06/24/1997 | US5641673 Polynucleotide molecule encoding trans-splicing ribozyme with rna sequence hybridizing to target rna encoding transcription activator protein fused to sequence to be trans-spliced into target rna, linked to transcription regulator |
| 06/24/1997 | US5641625 Peptide nucleic acids forming duplex, triplex and other structures with nucleic acids; modulation of protein activity by transcription arrest and initiation; specific site cleavage |
| 06/24/1997 | US5641487 Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides |
| 06/19/1997 | WO1997021815A2 Antifungal proteins |
| 06/19/1997 | WO1997021726A1 Agents for promoting bone formation |
| 06/19/1997 | WO1997010796A3 MANIPULATION AND DETECTION OF PROTEIN PHOSPHATASE 2C - PP2Cα - EXPRESSION IN TUMOR CELLS FOR CANCER THERAPY, PREVENTION AND DETECTION |
| 06/19/1997 | DE19546938A1 New carbamoyl substituted piperidine carbonyl peptide derivatives |
| 06/19/1997 | CA2239731A1 Antifungal proteins |
| 06/19/1997 | CA2236335A1 Agents for promoting bone formation |
| 06/18/1997 | EP0779297A1 Antigenic peptides with glycine substitutions |
| 06/18/1997 | EP0779076A1 Peptide, a method of obtaining it and a pharmaceutical compound based on it |
| 06/18/1997 | EP0778847A1 Immunostimulatory agents |
| 06/18/1997 | EP0512064B1 Extracellular segments of human ige immunoglobulin anchoring peptides and antibodies specific therefor |
| 06/18/1997 | CN1152338A Streptogramines and method for preparing same by mutasynthesis |
| 06/17/1997 | US5639885 Sustained delivery of pharmacologically active peptides to brain |
| 06/17/1997 | US5639863 Isolated dna which codes for a variable region of the antibody which is active against glioma antigen |
| 06/17/1997 | US5639860 Endothelin-antagonizing peptide |
| 06/17/1997 | US5639856 Proteins that are modulators of nerve cell growth and regeneration |
| 06/17/1997 | US5639852 Analogs of cyclosporin a |
| 06/17/1997 | US5639727 Therapeutic uses of bactericidal/permeability increasing protein products |
| 06/17/1997 | US5639601 Synthetic peptide sequences useful in detection of foot and mouth disease |
| 06/12/1997 | WO1997020927A1 Compounds having lectin properties and biological uses thereof |
| 06/12/1997 | WO1997020857A1 Cyclic dodecapeptide and process for the preparation thereof |
| 06/12/1997 | DE19545463A1 Organisch-chemische Verbindung und Verfahren zu ihrer Herstellung Organic chemical compound and processes for their preparation |
| 06/12/1997 | CA2237495A1 Compounds having lectin properties and biological uses thereof |
| 06/11/1997 | EP0777684A1 Calcitonin receptor |
| 06/11/1997 | EP0777679A1 Delivery of nucleic acids |
| 06/11/1997 | EP0777678A1 Pna combinatorial libraries and improved methods of synthesis |
| 06/11/1997 | EP0777493A1 Calcitonin gene related peptide receptor |
| 06/11/1997 | EP0446315B1 Process for the preparation of pai-2 |
| 06/11/1997 | CN1151700A Tri-, tetra-, penta- and polypeptides and their therapeutic use as an antidepressant agent |
| 06/10/1997 | US5637568 Composition for the sustained and controlled release of medicamentous substances and a process for preparing the same |
| 06/10/1997 | US5637565 Cocrystallization of different streptogramins |
| 06/10/1997 | US5637564 Hydrophilic part derived from sugar, polyol, aminopolyol; hydrophobic part derived from hydrocarbon, linked to hydrophilic part by junction bearing amino acid |
| 06/10/1997 | US5637492 Activatable fibrinolytic and anti-thrombotic proteins |
| 06/10/1997 | US5637201 Linker lipid for use in attaching a membrane, comprises with in the same molecule hydrophilic and hydrophobic regions |
| 06/05/1997 | WO1997019954A1 Targeted cytotoxic anthracycline analogs |
| 06/05/1997 | WO1997019953A2 New lh-rh antagonists with improved effectiveness |
| 06/05/1997 | WO1997019698A1 Diphtheria toxin epitopes |
| 06/05/1997 | WO1997010851A3 Nucleic acid delivery vehicle |
| 06/05/1997 | DE19544212A1 Neue LH-RH-Antagonisten mit verbesserter Wirkung New LH-RH antagonists with improved activity |
| 06/05/1997 | CA2239012A1 Diphtheria toxin epitopes |
| 06/05/1997 | CA2238570A1 New lh-rh antagonists with improved effectiveness |
| 06/04/1997 | EP0776336A1 Vitronectin binding protein |
| 06/04/1997 | EP0776335A1 Regulatable elimination of gene expression, gene product function and engineered host cells |
| 06/04/1997 | EP0776334A1 Stable analogs of bioactive peptides containing disulfide linkages |
| 06/04/1997 | EP0776333A1 Peptide antagonist intermediates of neurotensin |
| 06/04/1997 | EP0776331A1 Higher order structure and binding of peptide nucleic acids |
| 06/04/1997 | EP0776209A1 Polynucleic acids and proteins from a porcine reproductive and respiratory syndrome virus and uses thereof |
| 06/04/1997 | EP0544861A4 Immunoassay for non-a non-b hepatitis |
| 06/04/1997 | CN1151184A Human Monoclonal antibodies specific to cell cycle independent glioma surface antigen |
| 06/04/1997 | CN1151167A Isolated MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof |
| 06/04/1997 | CN1035056C Method for preparing cyclic neurokinin A antagonists |
| 06/03/1997 | US5635765 Semiconductors having first and second refractory metal silicide layers which have differing stoichiometries |
| 06/03/1997 | US5635615 High affinity HIV nucleocapsid nucleic acid ligands |
| 06/03/1997 | US5635597 Peptides that bind IL-2 receptors |
| 06/03/1997 | US5635593 Bradykinin antagonists |
| 06/03/1997 | US5635477 Cyclic compounds useful as inhibitors of platelet glycoprotein IIB/IIIA |
| 06/03/1997 | US5635379 Prepared from n-alpha-acetyl-2-alkyl tryptophan racemic mixture |
| 06/03/1997 | US5635371 Modifying dna sequence encoding recombinant polypeptide by adding sequence encoding protecting group having cleavage sequence, removing biologically added protecting group, modifying unprotected terminal amino acid, deprotecting |
| 06/03/1997 | US5635181 Pure immunogenic peptide encoded by dna sequence present in specified recombinant bacterial plasmid |
| 06/03/1997 | US5635177 Useful in enabling role of tyrosine kinase receptor in cell growth and differentiation |
| 06/03/1997 | CA2077651C Peptides stimulating cytotoxic t cells immune to hiv rt |
| 05/29/1997 | WO1997019169A1 Tumour vaccine and process for the preparation thereof |
| 05/29/1997 | WO1997019106A2 Collagen-like peptoid residue-containing structures |
| 05/29/1997 | WO1997019104A1 Cyclopeptolides |
| 05/29/1997 | WO1997018828A1 Inhibitors of cyclophilin rotamase activity |
| 05/29/1997 | WO1997018827A1 Compositions and methods for the prevention and treatment of oral mucositis |
| 05/29/1997 | WO1997018826A1 Fine tuned protegrins |
| 05/29/1997 | WO1997018822A1 Vertebrate deltex proteins, nucleic acids, and antibodies, and related methods and compositions |
| 05/29/1997 | CA2238610A1 Fine tuned protegrins |
| 05/29/1997 | CA2238429A1 Compositions and methods for the prevention and treatment of oral mucositis |
| 05/29/1997 | CA2238404A1 Vertebrate deltex proteins, nucleic acids, and antibodies, and related methods and compositions |
| 05/29/1997 | CA2238176A1 Tumour vaccine and process for the preparation thereof |
| 05/29/1997 | CA2237845A1 Collagen-like peptoid residue-containing structures |
| 05/28/1997 | EP0775160A1 Cyclic hexapeptide somatostatin analogues |
| 05/28/1997 | EP0775158A1 Organic compounds |
| 05/28/1997 | EP0774971A1 Synthetic peptide inhibitors of hiv transmission |
| 05/28/1997 | EP0571420B1 Mycobacterium polypeptides and nucleic acids encoding them for diagnosis and control of tuberculosis |
| 05/28/1997 | DE19543649A1 Tumour vaccine containing tumour cells loaded with peptide(s) that bind to MHC Class I |
| 05/28/1997 | CN1150805A Isolated peptides derived from MAGE tumor rejection antigen precursops which complex with HLA-A2 molecules |
| 05/28/1997 | CN1035006C Method for preparing peptide of effect having bradykinin-antagonistic agent |
| 05/27/1997 | US5633234 Lysosomal targeting of immunogens |
| 05/27/1997 | US5633230 Using an arginine containing oligopeptides |
| 05/27/1997 | US5633227 Secretory leukocyte protease inhibitor as an inhibitor of tryptase |
| 05/27/1997 | US5633158 Culture product; genetic engineering |
| 05/27/1997 | US5632993 Immunogens and the use thereof for obtaining antibodies against HbA1c |
| 05/27/1997 | US5632988 Containing the specific amino acid sequence arg-arg-lys-trp-gln in their structure |
| 05/27/1997 | CA1339047C Production of erythropoietin |
| 05/22/1997 | WO1997018307A1 Fas ligand fusion protein |
| 05/22/1997 | WO1997018239A1 Peptide conjugates derived from thymic hormones, their use as medicament and compositions containing them |
| 05/22/1997 | WO1997018236A1 MIMOTOPES AND ANTI-MIMOTOPES OF HUMAN PLATELET GLYCOPROTEIN Ib/IX |
| 05/22/1997 | WO1997018235A1 Peptide conjugates, use thereof as a drug, and compositions containing same |
| 05/22/1997 | WO1997018185A1 Lipopolyamines as transfection agents and pharmaceutical uses thereof |
| 05/22/1997 | WO1997009344A3 Librairies of backbone-cyclized peptidomimetics |
| 05/22/1997 | WO1997008304A3 Methodology to produce, purify and assay polypeptides with the proteolytic activity of the hcv ns3 protease |